Stay updated on Ixekizumab Delivery in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.

Latest updates to the Ixekizumab Delivery in Psoriasis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 has been added to the page, and the funding-lapse notice along with Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA site-wide funding-status notice was added and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' control and new metadata items (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed the previous lowercase/older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 updated from v3.3.3. This is a minor label change that does not affect content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations have been reorganized under a single Locations section and now list multiple states; the HHS Vulnerability Disclosure link was removed and a new revision note v3.3.3 was added.SummaryDifference2%

- Check91 days agoChange DetectedPublications section now specifies that publications are provided voluntarily by the person entering information about the study, and the page revision shows v3.3.2 (up from v3.2.0).SummaryDifference0.1%

Stay in the know with updates to Ixekizumab Delivery in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixekizumab Delivery in Psoriasis Clinical Trial page.